The disclosure relates to improving the visualization of medical devices, in particular, devices with lumens for fluid flow.
In order that the invention may be readily understood, embodiments of the invention are illustrated by way of examples in the accompanying drawings, in which:
Certain medical procedures require the use of a medical device that can: create punctures or channels into or through material; enable fluid delivery and/or withdrawal into/from the patient's body; and provide imaging markers for visualizing one or more steps of a medical procedure. Radiopaque bands placed on the outside of a shaft of a medical device are commonly used for imaging. Such external marker bands increase the outer diameter of a device and, in some cases, external dimensional restraints may require reduced outer diameter thereby preventing use of a device with such an external marker. Also, such external marker bands are commonly proximal of the furthermost tip of the device such that the bands do not provide for precise positioning of the tip of a device. To avoid increasing the outer diameter of a device, imaging markers may be placed inside of the device's lumen, but: a) this is often not easily achievable, depending on the size and configuration (material, etc.) of the device and the diameter of the lumen defined by the device; and b) this generally obstructs fluid flow through the lumen of the device.
The present inventors have discovered and reduced to practice several embodiments described herein allowing for improving visualization of a portion of a medical device for inserting into a patient while minimizing obstruction of fluid flow through a lumen and, in addition, avoiding an increase in the outer diameter of the device. This may be accomplished, for example, by providing a radiopaque marker distal to lumen openings (exit ports/apertures) where the diameter of the marker is less than or equal to the diameter of a portion of the device adjacent the marker, or, where the device comprises a metallic tube or similar structure, by providing an imaging marker substantially embedded into/within a wall of the tube.
One specific embodiment includes a hemispherical atraumatic distal tip comprising radiopaque material fusion-welded with the end of a metal tube to form a radiopaque electrode tip at the distal tip of the device. The radiopaque electrode tip provides for both positioning of the distal end of the device and delivering energy, while the atraumatic shape largely limits or prevents accidental damage to tissue. This embodiment may also include longitudinally extended lateral side ports (lateral apertures) for fluid flow. Aspects of the embodiments described herein can also be included in other types of devices, for example, devices without a lumen for fluid flow, and devices not providing energy delivery.
In a first broad aspect, embodiments of the present invention include a medical device comprising an elongated member having a proximal end, a distal end, and a metal tube including an open distal end which is forward facing, the metal tube defining a lumen extending substantially between the proximal end and the distal end of the elongated member, and the elongated member defining a side port from the lumen to an environment outside of the elongated member. An electrode extends distally of the open distal end of the metal tube to define a distal tip of the medical device, with the electrode being configured for delivering electrical energy, wherein the electrical energy is delivered to the electrode through the metal tube. An imaging marker is comprised of an electrically conductive metal associated with the elongated member at a marker location, with the imaging marker being in electrical communication with the metal tube of the elongated member, wherein the medical device is configured such that, in use, a flow of fluid through the lumen to the side port is not substantially obstructed by the imaging marker. The imaging marker is located at the distal end of the metal tube, wherein the imaging marker substantially occludes the lumen at the distal end of the metal tube to prevent the flow of fluid in the lumen flowing past the marker location, and a portion of the imaging marker fills a portion of the lumen between the side port and the distal end of the elongated member and another portion of the imaging marker extends beyond the open distal end of the metal tube to outside of the lumen to define at least part of the electrode.
In typical embodiments of the first broad aspect, the portion of the imaging marker which fills the portion of the lumen has a cylindrical shape and a solid cross-section. Typical embodiments include the electrode being round shaped and atraumatic such that the electrode extends distally of the open distal end of the metal tube to define a distal tip of the medical device being round shaped and atraumatic. Alternative embodiments include the electrode having a pointed shape such that the electrode extends distally of the open distal end of the metal tube to define a distal tip of the medical device having a pointed shape. In typical embodiments, an outer diameter of the medical device at the marker location is substantially equal to the outer diameter of the medical device adjacent to the marker location.
Typical embodiments of the first broad aspect comprise a layer of insulation which covers the metal tube to distal of the side port and leaves a distal portion of the metal tube exposed, and the distal end of the elongated member comprising a functional tip which includes the imaging marker and the electrode, wherein the imaging marker is comprised of electrically conductive metal attached to the distal portion of the metal tube, and the electrode is comprised of the portion of the functional tip which extends beyond the layer of insulation. In some such embodiments, the imaging marker is comprised of metal which is more radiopaque than the metal tube. In some embodiments, the imaging marker is substantially comprised of a radiopaque material.
In some embodiments of the first broad aspect, the medical device further comprises a layer of insulation covering at least some of the elongated member and slightly overlapping a perimeter of the side port to thereby prevent the metal tube from contacting a surrounding tissue while not covering a center of the side port to define an overlap which does not contact the metal tube. In some such embodiments, the side port is longitudinally elongated to provide for increased fluid flow.
In some embodiments of the first broad aspect, the imaging marker is an echogenic marker. In some embodiments, the imaging marker is a marker visible under magnetic resonance imaging. Some embodiments comprise the imaging marker being a radiopaque marker comprising a radiopaque material selected from the group consisting of platinum, iridium, gold, palladium, tungsten, and alloys thereof. In some embodiments having a radiopaque marker, the radiopaque material is comprised of about 90% platinum and about 10% iridium. In some embodiments having a radiopaque marker, the radiopaque material is comprised of about 92% platinum and about 8% tungsten.
Some embodiments of the first broad aspect include a layer of electrical insulation along an outer surface of the metal tube. In some examples, the metal tube is comprised of a proximal metal tube and a distal metal end member in electrical communication with the proximal metal tube. Examples having a proximal metal tube and a distal metal end member typically include a layer of insulation covering at least some of the proximal metal tube and some of the distal metal end member, leaving a distal portion of the distal metal end member exposed to define at least a part of the electrode. In some such examples, the distal metal end member defines the open distal end of the metal tube and where the distal metal end member includes a functional tip which includes the electrode and the imaging marker, wherein the imaging marker is comprised of electrically conductive metal attached to a distal portion of the distal metal end member, and the electrode is comprised of the portion of the functional tip which extends beyond the layer of insulation. Some such examples include the layer of insulation which covers the metal tube extending beyond the metal tube to cover a portion of the functional tip which is proximal of the electrode.
In some embodiments of the first broad aspect, the elongated member comprises a plastic tube and in others the elongated member comprises a metal tube. The elongated member can alternatively be a round tube, a coil, a braid or a conduit that is not round. Embodiments having a metal tube can further comprise the imaging marker being attached to the metal tube by welding, and further that the functional tip is formed by fusion welding of a distal end of the metal tube and a radiopaque filler or other radiopaque material with the functional tip possibly having at least a dome or hemispherical-shaped portion and that the functional tip blocks the distal end of the lumen.
In a second broad aspect, embodiments of the present invention include a method of creating a channel or perforation at a target location in a body of a patient, using a medical device comprising an elongated member and a functional tip associated with the elongated member and located about a distal end of the elongated member, at least a portion of the functional tip being visible using a medical imaging modality, the method comprising the steps of: a) visualizing the functional tip as the medical device is advanced through the patient's body to guide the functional tip to the target location; c) positioning the functional tip at the target location; and d) delivering electrical energy through an electrode of the functional tip to create the channel or perforation.
Some embodiments of the method of creating a channel or perforation at a target location in a body of a patient comprise the steps of: a) introducing a medical device comprising an elongated member, and a functional tip associated with and located at/about a distal end of the elongated member, into the vasculature of the patient, b) advancing the medical device through the vasculature using the functional tip as a radiopaque marker for imaging of the distal end whereby the distal end can be steered, c) positioning the functional tip to the target location, and d) delivering electrical energy through an electrode of the functional tip electrode to create the channel.
In some embodiments of the second broad aspect, the elongated member defines a lumen and the medical device has at least one opening from the lumen to the environment outside of the elongated member and the method further comprises the step of fluid flowing through the opening. In some embodiments, a distal end of the lumen is closed and the elongated member has at least one lateral aperture (side port) from the lumen to the environment outside of the elongated member, and the method further comprises the step of fluid flowing through the sideport. Fluids, such as fluids visible under imaging, can be delivered or withdrawn.
In some embodiments of the second broad aspect, step b) further comprises advancing the elongated member through the vasculature without substantial coring of tissue. In some embodiments, step d) further comprises creating the channel without substantial coring of tissue.
In some embodiments of the second broad aspect, the functional tip has a diameter that is less than or equal to an outer diameter of the elongated member (the shaft of the device) to thereby ease or facilitate the advancement of the elongated member through vasculature i.e. the functional tip does not increase the outer diameter of the device, which would make advancement more difficult.
Optionally, in some embodiments, the energy that is delivered in step d) is radio frequency electrical energy.
In some embodiments of the second aspect of the invention, the elongated member defines a lumen and the medical device has at least one opening from the lumen to an environment outside of the elongated member, and the method further comprises the step of using fluid to sense pressure. In some such embodiments, the fluid comprises a liquid. In alternative embodiments, the fluid comprises a gas. In other alternative, the fluid comprises particles of solid that can flow, possibly echogenic marker beads.
In alternative embodiments of the medical device, an imaging marker can be echogenic, magnetic (i.e. a marker visible using magnetic resonance imaging) or some other type of imaging marker. Consequently, while some of the embodiments of this disclosure are described as having radiopaque markers, said radiopaque markers can have replaced by or supplemented by said echogenic markers, magnetic (i.e. a marker visible using magnetic resonance imaging) markers or other types of markers to result in alternative embodiments. Furthermore, while the end of the functional tip is shown as being dome-shaped in some of the figures, it can be other shapes, including, but not limited to, pointed or knife-like.
With specific reference now to the drawings, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of certain embodiments of the present invention only. Before explaining embodiments of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
For the purposes of this description, proximal indicates next to or nearer to the user, and distal indicates further away from the user. In addition, alternative terminology has been used throughout the specification and is generally indicated by the use of regular brackets such as ( ). Furthermore, although several embodiments are described in conjunction with metal, metallic tubes, etc., it should be noted that other materials exhibiting similar material characteristics, such as electrical conductivity, are included as well.
One possible general embodiment of a device 20 is shown in
Making reference to
This embodiment also includes lumen 9 and lateral aperture (side port opening) 7 for movement of fluid between the lumen and the environment outside of the device. Lumen 9 is blocked (or closed) at the distal end of end member 10 by functional tip 15. Opening 7 is closer to the proximal end of elongated member 2 than is functional tip 15, whereby functional tip 15 does not obstruct fluid flowing through opening 7. Electricity may be delivered through metal tube 8 and end member 10 to electrode 3.
The embodiment of
Several views of an additional embodiment similar to that of
Another embodiment similar to that of
The embodiments found in
For the embodiments of
One method of making the embodiment of
Alternatively, other materials could be used in the embodiment of
Alternative embodiments of
The embodiments found in
The embodiment of
The embodiment of
The configuration of the basic components as illustrated in
Some possible options for the above described fusion welding process include tubular component 16 being made with different materials (plastics, metals, etc.), as can the filler. Before welding, the filler can have different shapes and does not have to closely fit the inner diameter of tubular component 16. The filler can comprise a single piece or part, or a plurality of pieces or parts, including particles as small as powder.
The medical device of the disclosure may be used with a source of radiofrequency (RF) energy for creating a channel at a target location in a body of a patient. One such embodiment comprises the steps of: a) introducing a medical device 20 having an elongated member 2 and a distal end functional tip 15 into the vasculature of a patient, b) advancing elongated member 2 through the vasculature using radiopaque marker 6 of functional tip 15 for imaging whereby functional tip 15 (which has an electrode 3) can be steered, c) positioning electrode 3 of functional tip 15 (which is operable to deliver energy) at the target location, and d) delivering electrical energy through electrode 3 to create the channel.
An opening (aperture) 7 can be used to deliver fluid from a lumen 9 of elongated member 2 to the target location. In some embodiments, having the distal end of lumen 9 closed by functional tip 15 and having an opening 7 that is a side port (such as in
In one specific embodiment of a method of using the disclosed medical device, for example as illustrated in
In one such embodiment, an intended user introduces a guidewire into a femoral vein, typically the right femoral vein, and advances it towards the heart. A guiding sheath 30, for example a sheath as described in U.S. patent application Ser. No. 10/666,288 (filed on Sep. 10, 2003), incorporated herein by reference in its entirety, is then introduced into the femoral vein over the guidewire, and advanced towards the heart. The distal ends of the guidewire and sheath 30 are then positioned in the superior vena cava. These steps may be performed with the aid of an imaging system appropriate for marker 6. When the sheath 30 is in position, a dilator 28, for example the TorFlex™ Transseptal Dilator of Baylis Medical Company Inc. (Montreal, Canada), or the dilator as described in U.S. patent application Ser. No. 11/727,382 (filed on Mar. 26, 2007), incorporated herein by reference in its entirety, is introduced into the sheath 30 and over the guidewire, and advanced through the sheath into the superior vena cava. The sheath 30 may aid in preventing the dilator 28 from damaging or puncturing vessel walls, for example, in embodiments comprising a substantially stiff dilator. Alternatively, the dilator 28 may be fully inserted into the sheath 30 prior to entering the body, and both may be advanced simultaneously towards the heart. When the guidewire, sheath 30, and dilator 28 have been positioned in the superior vena cava, the guidewire is removed from the body, and the sheath and dilator are retracted slightly, such that they enter the right atrium of the heart. An electrosurgical device, for example radiofrequency perforation apparatus 20 described hereinabove, is then introduced into the lumen of the dilator, and advanced toward the heart.
In this embodiment, after inserting the electrosurgical device into a dilator 28, the user may position the distal end of the dilator against the atrial septum 32. The electrosurgical device is then positioned using imaging of a marker 6 of functional tip 15 such that electrode 3 is aligned with or protruding slightly from the distal end of the dilator 28 but not pulled back inside of the dilator. The dilator 28 and medical device 20 are dragged along the atrial septum 32 and positioned, for example against the fossa ovalis of the atrial septum using imaging of a marker 6 of functional tip 15. A variety of additional steps may be performed, such as measuring one or more properties of the target site, for example an electrogram or ECG (electrocardiogram) tracing and/or a pressure measurement, or delivering material to the target site, for example delivering a contrast agent through aperture(s) 7 and/or an open distal end. Such steps may facilitate the localization of the electrode 3 at the desired target site. In addition, tactile feedback provided by medical device 20 (radiofrequency perforation apparatus 20) is usable to facilitate positioning of the electrode 3 at the desired target site. The practitioner can visually monitor the position of functional tip 15 as it is advanced upwards into the heart and as it is dragged along the surface of the atrial septum 32 and positioned in the groove of the fossa ovalis.
With the electrosurgical device and the dilator positioned at the target site, energy is delivered from the energy source, through medical device 20 (radiofrequency perforation apparatus 20), to the target site. For example, if the radiofrequency perforation apparatus 20 is used, energy is delivered through the elongated member 2, to the electrode 3, and into the tissue at the target site. In some embodiments, the energy is delivered at a power of at least about 5 W at a voltage of at least about 75 V (peak-to-peak), and functions to vaporize cells in the vicinity of the electrode, thereby creating a void or perforation through the tissue at the target site. If the heart was approached via the inferior vena cava, as described hereinabove, the user applies force in the substantially cranial direction to the handle 1 of the electrosurgical device as energy is being delivered. The force is then transmitted from the handle to the distal portion 4 of the radiofrequency perforation apparatus 20, such that the distal portion 4 advances at least partially through the perforation. In these embodiments, when the distal portion 4 has passed through the target tissue, that is, when it has reached the left atrium, energy delivery is stopped. In some embodiments, the step of delivering energy occurs over a period of between about 1 s and about 5 s.
Some embodiments of methods of using the disclosed medical device comprise using a medical device 20 with a functional tip 15 that can be seen inside a substantially radiopaque dilator. Functional tip 15 includes a tip marker 6 with sufficient radiopacity that it can be seen under fluoroscopy. Medical device 20 may be used with a radiopaque dilator that can also be seen under fluoroscopy but that allows tip marker 6 to be seen within it. Substantially most, or all, of the dilator can be radiopaque, or just a distal portion of it. The use of tip maker 6 with such a compatible dilator can allow a physician to position functional tip 15 relative to the end of the dilator. For example, a physician could ensure that the tip of medical device 20 only protrudes out of the dilator 28 at the desired point in time. When performing a transseptal procedure using fluoroscopy, the radiopaque dilator can be positioned against the septum prior to crossing and the physician can maintain the tip of medical device within the dilatator. Since functional tip 15 can be seen inside of the dilator 28, it can be positioned just inside of the dilator tip immediately prior to attempting the transseptal crossing. It is only when the physician chooses to attempt to the crossing that an electrode 3 of a radiofrequency perforation apparatus 20 need be extended from the dilator. The physician can avoid having functional tip 15 accidentally extend beyond the end of the dilator before it is necessary.
It is also possible that the radiopaque-tipped radiofrequency perforation apparatus 20 and dilator 28 could be used with a catheter with a radiopaque marker at its tip to increase visibility and offer greater control to the physician.
As described herein above, medical devices are disclosed having improved visualization of a portion of the medical device insertable into a patient's body while minimizing obstruction of fluid flow through a lumen of the device and while minimizing an increase in the outer diameter of the device attributable to the feature providing improved visualization. The device can include, for example, an imaging marker distal to lumen openings (exit ports), or, where the device comprises a tube, such as a metallic tube, an imaging marker embedded into a wall of the tube. An alternative embodiment includes attaching a marker to the surface on the inside of a lumen of a medical device without substantially embedding the marker. Various alternative embodiments, methods and applications of using such devices are disclosed as well.
Additional details regarding the device and method not mentioned herein may be found in U.S. application Ser. No. 11/905,447, filed Oct. 1, 2007, U.S. application Ser. No. 13/113,326, filed May 23, 2007 U.S. application Ser. No. 11/265,304, filed Nov. 3, 2005 (now U.S. Pat. No. 7,947,040), U.S. application Ser. No. 10/666,301, filed Sep. 19, 2003 (now issued as U.S. Pat. No. 7,048,733), U.S. application Ser. No. 10/760,479, filed Jan. 21, 2004 (now issued as U.S. Pat. No. 7,270,662), U.S. application Ser. No. 10/666,288, filed Sep. 19, 2003, U.S. application Ser. No. 10/347,366, filed Jan. 21, 2003 (now issued as U.S. Pat. No. 7,112,197), U.S. provisional application Ser. No. 60/522,753, filed Nov. 3, 2004, and provisional applications Ser. No. 60/884,285, filed Jan. 10, 2007 and 60/827,452, filed Sep. 29, 2006. The contents of all above-named applications and patents are incorporated herein by reference in their entirety.
The embodiments of the invention described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the scope of the appended claims.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.
Number | Name | Date | Kind |
---|---|---|---|
175254 | Oberly | Mar 1876 | A |
827626 | Gillet | Jul 1906 | A |
848711 | Daniel | Apr 1907 | A |
1072954 | Junn | Sep 1913 | A |
1279654 | Charlesworth | Sep 1918 | A |
1918094 | Geekas | Jul 1933 | A |
1996986 | Weinberg | Apr 1935 | A |
2021989 | De Master | Nov 1935 | A |
2146636 | Lipchow | Feb 1939 | A |
3429574 | Williams | Feb 1969 | A |
3448739 | Stark et al. | Jun 1969 | A |
3575415 | Fulp et al. | Apr 1971 | A |
3595239 | Petersen | Jul 1971 | A |
4029102 | Barger | Jun 1977 | A |
4129129 | Amrine | Dec 1978 | A |
4244362 | Anderson | Jan 1981 | A |
4401124 | Guess et al. | Aug 1983 | A |
4577637 | Mueller, Jr. | Mar 1986 | A |
4639252 | Kelly et al. | Jan 1987 | A |
4641649 | Walinsky et al. | Feb 1987 | A |
4669467 | Willett et al. | Jun 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4790311 | Ruiz | Dec 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
4793350 | Mar et al. | Dec 1988 | A |
4807620 | Strul et al. | Feb 1989 | A |
4832048 | Cohen | May 1989 | A |
4840622 | Hardy | Jun 1989 | A |
4863441 | Lindsay et al. | Sep 1989 | A |
4884567 | Elliott et al. | Dec 1989 | A |
4892104 | Ito et al. | Jan 1990 | A |
4896671 | Cunningham et al. | Jan 1990 | A |
4928693 | Goodin et al. | May 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4977897 | Hurwitz | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5006119 | Acker et al. | Apr 1991 | A |
5019076 | Yamanashi et al. | May 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5081997 | Bosley et al. | Jan 1992 | A |
5097843 | Soukup et al. | Mar 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5112048 | Kienle | May 1992 | A |
5154724 | Andrews | Oct 1992 | A |
5201756 | Horzewski et al. | Apr 1993 | A |
5209741 | Spaeth | May 1993 | A |
5211183 | Wilson | May 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5230349 | Langberg | Jul 1993 | A |
5281216 | Klicek | Jan 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5314418 | Takano et al. | May 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5327905 | Avitall | Jul 1994 | A |
5364393 | Auth et al. | Nov 1994 | A |
5372596 | Klicek et al. | Dec 1994 | A |
5380304 | Parker | Jan 1995 | A |
5397304 | Truckai | Mar 1995 | A |
5403338 | Milo | Apr 1995 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5423809 | Klicek | Jun 1995 | A |
5425382 | Golden et al. | Jun 1995 | A |
5485667 | Kleshinski | Jan 1996 | A |
5488959 | Ales | Feb 1996 | A |
5489277 | Tolkoff et al. | Feb 1996 | A |
5490859 | Mische et al. | Feb 1996 | A |
5497774 | Swartz et al. | Mar 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5509411 | Littmann et al. | Apr 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5545200 | West et al. | Aug 1996 | A |
5555618 | Winkler | Sep 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5575766 | Swartz et al. | Nov 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5599347 | Hart et al. | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5622169 | Golden et al. | Apr 1997 | A |
5624430 | Eton et al. | Apr 1997 | A |
5640970 | Arenas | Jun 1997 | A |
5667488 | Lundquist et al. | Sep 1997 | A |
5673695 | McGee et al. | Oct 1997 | A |
5674208 | Berg et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5741249 | Moss et al. | Apr 1998 | A |
5766135 | Terwilliger | Jun 1998 | A |
5779688 | Imran et al. | Jul 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5814028 | Swartz et al. | Sep 1998 | A |
5830214 | Flom et al. | Nov 1998 | A |
5836875 | Webster, Jr. | Nov 1998 | A |
5849011 | Jones et al. | Dec 1998 | A |
5851210 | Torossian | Dec 1998 | A |
5885227 | Finlayson | Mar 1999 | A |
5888201 | Stinson et al. | Mar 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5893885 | Webster, Jr. | Apr 1999 | A |
5904679 | Clayman | May 1999 | A |
5916210 | Winston | Jun 1999 | A |
5919188 | Shearon et al. | Jul 1999 | A |
5921957 | Killion et al. | Jul 1999 | A |
5921978 | Thompson et al. | Jul 1999 | A |
5931818 | Werp et al. | Aug 1999 | A |
5944023 | Johnson et al. | Aug 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5957842 | Littmann et al. | Sep 1999 | A |
5964757 | Ponzi | Oct 1999 | A |
5967976 | Larsen et al. | Oct 1999 | A |
5989276 | Houser et al. | Nov 1999 | A |
6007555 | Devine | Dec 1999 | A |
6009877 | Edwards | Jan 2000 | A |
6013072 | Winston et al. | Jan 2000 | A |
6017340 | Cassidy et al. | Jan 2000 | A |
6018676 | Davis et al. | Jan 2000 | A |
6030380 | Auth et al. | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6048349 | Winston et al. | Apr 2000 | A |
6053870 | Fulton, III | Apr 2000 | A |
6053904 | Scribner et al. | Apr 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6063093 | Winston et al. | May 2000 | A |
6093185 | Ellis et al. | Jul 2000 | A |
6106515 | Winston et al. | Aug 2000 | A |
6106520 | Laufer et al. | Aug 2000 | A |
6117131 | Taylor | Sep 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6146380 | Racz et al. | Nov 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6156031 | Aita et al. | Dec 2000 | A |
6171305 | Sherman | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6193715 | Wrublewski et al. | Feb 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217575 | Devore et al. | Apr 2001 | B1 |
6221061 | Engelson et al. | Apr 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6245054 | Fuimaono et al. | Jun 2001 | B1 |
6267758 | Daw et al. | Jul 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6285903 | Rosenthal et al. | Sep 2001 | B1 |
6292678 | Hall et al. | Sep 2001 | B1 |
6293945 | Parins et al. | Sep 2001 | B1 |
6296615 | Brockway et al. | Oct 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6302898 | Edwards et al. | Oct 2001 | B1 |
6304769 | Arenson et al. | Oct 2001 | B1 |
6315777 | Comben | Nov 2001 | B1 |
6328699 | Eigler et al. | Dec 2001 | B1 |
6360128 | Kordis et al. | Mar 2002 | B2 |
6364877 | Goble et al. | Apr 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6394976 | Winston et al. | May 2002 | B1 |
6395002 | Ellman et al. | May 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6419674 | Bowser et al. | Jul 2002 | B1 |
6428551 | Hall et al. | Aug 2002 | B1 |
6450989 | Dubrul | Sep 2002 | B2 |
6475214 | Moaddeb | Nov 2002 | B1 |
6485485 | Winston et al. | Nov 2002 | B1 |
6501992 | Belden et al. | Dec 2002 | B1 |
6508754 | Liprie et al. | Jan 2003 | B1 |
6520934 | Lee et al. | Feb 2003 | B1 |
6524303 | Garibaldi | Feb 2003 | B1 |
6530923 | Dubrul | Mar 2003 | B1 |
6554827 | Chandrasekaran et al. | Apr 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6562049 | Norlander et al. | May 2003 | B1 |
6565562 | Shah et al. | May 2003 | B1 |
6607529 | Jones et al. | Aug 2003 | B1 |
6632227 | Edwards et al. | Oct 2003 | B2 |
6639999 | Cookingham et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6651672 | Roth | Nov 2003 | B2 |
6662034 | Segner et al. | Dec 2003 | B2 |
6663621 | Winston et al. | Dec 2003 | B1 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6709444 | Makower | Mar 2004 | B1 |
6723052 | Mills | Apr 2004 | B2 |
6733511 | Hall et al. | May 2004 | B2 |
6740103 | Hall et al. | May 2004 | B2 |
6752800 | Winston et al. | Jun 2004 | B1 |
6755816 | Ritter et al. | Jun 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6814733 | Schwartz et al. | Nov 2004 | B2 |
6820614 | Bonutti | Nov 2004 | B2 |
6832715 | Eungard et al. | Dec 2004 | B2 |
6834201 | Gillies et al. | Dec 2004 | B2 |
6842639 | Winston et al. | Jan 2005 | B1 |
6852109 | Winston et al. | Feb 2005 | B2 |
6855143 | Davison et al. | Feb 2005 | B2 |
6860856 | Ward et al. | Mar 2005 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6911026 | Hall et al. | Jun 2005 | B1 |
6951554 | Johansen et al. | Oct 2005 | B2 |
6951555 | Suresh et al. | Oct 2005 | B1 |
6955675 | Jain | Oct 2005 | B2 |
6970732 | Winston et al. | Nov 2005 | B2 |
6980843 | Eng et al. | Dec 2005 | B2 |
7029470 | Francischelli et al. | Apr 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7083566 | Tornes et al. | Aug 2006 | B2 |
7112197 | Hartley et al. | Sep 2006 | B2 |
7169118 | Reynolds et al. | Jan 2007 | B2 |
7277762 | Belden et al. | Oct 2007 | B2 |
7335197 | Sage et al. | Feb 2008 | B2 |
7618430 | Scheib | Nov 2009 | B2 |
7651492 | Wham | Jan 2010 | B2 |
7666203 | Chanduszko et al. | Feb 2010 | B2 |
7678081 | Whiting et al. | Mar 2010 | B2 |
7682360 | Guerra | Mar 2010 | B2 |
7828796 | Wong et al. | Nov 2010 | B2 |
7862563 | Cosman | Jan 2011 | B1 |
7900928 | Held et al. | Mar 2011 | B2 |
7925358 | Belden et al. | Apr 2011 | B2 |
8192425 | Mirza et al. | Jun 2012 | B2 |
8257323 | Joseph et al. | Sep 2012 | B2 |
8388549 | Paul et al. | Mar 2013 | B2 |
8500697 | Kurth et al. | Aug 2013 | B2 |
10898291 | Davies | Jan 2021 | B2 |
11339579 | Stearns | May 2022 | B1 |
20010012934 | Chandrasekaran et al. | Aug 2001 | A1 |
20010021867 | Kordis et al. | Sep 2001 | A1 |
20020019644 | Hastings et al. | Feb 2002 | A1 |
20020022781 | McIntire et al. | Feb 2002 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20020087153 | Roschak et al. | Jul 2002 | A1 |
20020087156 | Maguire et al. | Jul 2002 | A1 |
20020095148 | Kinsella et al. | Jul 2002 | A1 |
20020111618 | Stewart et al. | Aug 2002 | A1 |
20020120259 | Lettice et al. | Aug 2002 | A1 |
20020123749 | Jain | Sep 2002 | A1 |
20020147485 | Mamo et al. | Oct 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020188302 | Berg et al. | Dec 2002 | A1 |
20020198521 | Maguire | Dec 2002 | A1 |
20030032929 | McGuckin | Feb 2003 | A1 |
20030040742 | Underwood et al. | Feb 2003 | A1 |
20030144658 | Schwartz et al. | Jul 2003 | A1 |
20030158480 | Tornes et al. | Aug 2003 | A1 |
20030163153 | Scheib | Aug 2003 | A1 |
20030225392 | McMichael et al. | Dec 2003 | A1 |
20040015162 | McGaffigan | Jan 2004 | A1 |
20040024396 | Eggers | Feb 2004 | A1 |
20040030328 | Eggers et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040073243 | Sepetka et al. | Apr 2004 | A1 |
20040077948 | Violante et al. | Apr 2004 | A1 |
20040101564 | Rioux et al. | May 2004 | A1 |
20040116851 | Johansen et al. | Jun 2004 | A1 |
20040127963 | Uchida et al. | Jul 2004 | A1 |
20040133113 | Krishnan | Jul 2004 | A1 |
20040133130 | Ferry et al. | Jul 2004 | A1 |
20040143256 | Bednarek | Jul 2004 | A1 |
20040143261 | Hartley et al. | Jul 2004 | A1 |
20040143262 | Visram et al. | Jul 2004 | A1 |
20040147950 | Mueller et al. | Jul 2004 | A1 |
20040167436 | Reynolds | Aug 2004 | A1 |
20040181213 | Gondo | Sep 2004 | A1 |
20040230188 | Cioanta et al. | Nov 2004 | A1 |
20050004585 | Hall et al. | Jan 2005 | A1 |
20050010208 | Winston et al. | Jan 2005 | A1 |
20050049628 | Schweikert et al. | Mar 2005 | A1 |
20050059966 | McClurken et al. | Mar 2005 | A1 |
20050065507 | Hartley et al. | Mar 2005 | A1 |
20050080410 | Rioux et al. | Apr 2005 | A1 |
20050085806 | Auge et al. | Apr 2005 | A1 |
20050096529 | Cooper et al. | May 2005 | A1 |
20050101984 | Chanduszko et al. | May 2005 | A1 |
20050119556 | Gillies et al. | Jun 2005 | A1 |
20050137527 | Kunin | Jun 2005 | A1 |
20050149012 | Penny et al. | Jul 2005 | A1 |
20050159738 | Visram et al. | Jul 2005 | A1 |
20050203504 | Wham et al. | Sep 2005 | A1 |
20050203507 | Truckai et al. | Sep 2005 | A1 |
20050261607 | Johansen et al. | Nov 2005 | A1 |
20050288631 | Lewis et al. | Dec 2005 | A1 |
20060041253 | Newton et al. | Feb 2006 | A1 |
20060074398 | Whiting et al. | Apr 2006 | A1 |
20060079769 | Whiting et al. | Apr 2006 | A1 |
20060079787 | Whiting et al. | Apr 2006 | A1 |
20060079884 | Manzo et al. | Apr 2006 | A1 |
20060085054 | Zikorus et al. | Apr 2006 | A1 |
20060089638 | Carmel et al. | Apr 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060135962 | Kick et al. | Jun 2006 | A1 |
20060142756 | Davies et al. | Jun 2006 | A1 |
20060189972 | Grossman | Aug 2006 | A1 |
20060241586 | Wilk | Oct 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20060264927 | Ryan | Nov 2006 | A1 |
20060276710 | Krishnan | Dec 2006 | A1 |
20070060879 | Weitzner et al. | Mar 2007 | A1 |
20070066975 | Wong et al. | Mar 2007 | A1 |
20070118099 | Trout, III | May 2007 | A1 |
20070123964 | Davies et al. | May 2007 | A1 |
20070167775 | Kochavi et al. | Jul 2007 | A1 |
20070185522 | Davies et al. | Aug 2007 | A1 |
20070208256 | Marilla | Sep 2007 | A1 |
20070225681 | House | Sep 2007 | A1 |
20070270791 | Wang et al. | Nov 2007 | A1 |
20070293924 | Belden et al. | Dec 2007 | A1 |
20070299461 | Elliott | Dec 2007 | A1 |
20080039834 | MacKay | Feb 2008 | A1 |
20080039865 | Shaher et al. | Feb 2008 | A1 |
20080042360 | Veikley | Feb 2008 | A1 |
20080086120 | Mirza | Apr 2008 | A1 |
20080097213 | Carlson et al. | Apr 2008 | A1 |
20080108902 | Nita et al. | May 2008 | A1 |
20080108987 | Bruszewski et al. | May 2008 | A1 |
20080146918 | Magnin et al. | Jun 2008 | A1 |
20080161794 | Wang et al. | Jul 2008 | A1 |
20080171934 | Greenan et al. | Jul 2008 | A1 |
20080194999 | Yamaha et al. | Aug 2008 | A1 |
20080208121 | Youssef et al. | Aug 2008 | A1 |
20080275439 | Francischelli et al. | Nov 2008 | A1 |
20090105742 | Kurth et al. | Apr 2009 | A1 |
20090138009 | Mswanathan et al. | May 2009 | A1 |
20090163850 | Betts et al. | Jun 2009 | A1 |
20090163913 | Wang | Jun 2009 | A1 |
20090177114 | Chin et al. | Jul 2009 | A1 |
20090264977 | Bruszewski et al. | Oct 2009 | A1 |
20100076404 | Ring | Mar 2010 | A1 |
20100087789 | Leeflang et al. | Apr 2010 | A1 |
20100125282 | Machek et al. | May 2010 | A1 |
20100168684 | Ryan | Jul 2010 | A1 |
20100179632 | Bruszewski et al. | Jul 2010 | A1 |
20100191142 | Paul et al. | Jul 2010 | A1 |
20100194047 | Sauerwine | Aug 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20110046619 | Ducharme | Feb 2011 | A1 |
20110118735 | Abou-Marie et al. | May 2011 | A1 |
20110152716 | Chudzik et al. | Jun 2011 | A1 |
20110160592 | Mitchell | Jun 2011 | A1 |
20110190763 | Urban et al. | Aug 2011 | A1 |
20120029444 | Anderson et al. | Feb 2012 | A1 |
20120172857 | Harrison | Jul 2012 | A1 |
20120232546 | Mirza et al. | Sep 2012 | A1 |
20120265055 | Melsheimer et al. | Oct 2012 | A1 |
20120330156 | Brown et al. | Dec 2012 | A1 |
20130184551 | Paganelli et al. | Jul 2013 | A1 |
20130184735 | Fischell et al. | Jul 2013 | A1 |
20130282084 | Mathur et al. | Oct 2013 | A1 |
20140206987 | Urbanski et al. | Jul 2014 | A1 |
20140296769 | Hyde et al. | Oct 2014 | A1 |
20160220741 | Garrison et al. | Aug 2016 | A1 |
20190021763 | Zhou et al. | Jan 2019 | A1 |
20190247035 | Gittard et al. | Aug 2019 | A1 |
Number | Date | Country |
---|---|---|
0513836 | Nov 1992 | EP |
S5996036 | Jun 1984 | JP |
H0280058 | Mar 1990 | JP |
H 10-43302 | Feb 1998 | JP |
2004216130 | Aug 2004 | JP |
2007-508113 | Apr 2007 | JP |
2008508969 | Mar 2008 | JP |
2008-194457 | Aug 2008 | JP |
2008-529610 | Aug 2008 | JP |
2008-245765 | Oct 2008 | JP |
2008245765 | Oct 2008 | JP |
2017512569 | Jul 2017 | JP |
2008098203 | Aug 2008 | WO |
2008098203 | Aug 2008 | WO |
2009158060 | Dec 2009 | WO |
2012014860 | Feb 2012 | WO |
2012044897 | Apr 2012 | WO |
Entry |
---|
Japanese Office Action from corresponding JPO application 2021-126774, dated Jun. 29, 2022, Japan Patent Office, 5 pages. |
Japanese Office Action from corresponding JPO application 2021-126775, dated Jun. 29, 2022, Japan Patent Office, 5 pages. |
Extended European Search Report from corresponding EPO Application No. 21215791.1, dated Apr. 4, 2022, European Patent Office, 8 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/IB2012/056315, dated Jul. 30, 2013, 12 pages. |
Patent Cooperation Treaty, International Preliminary Report on Patentability, International Application No. PCT/IB2012/056315, dated Dec. 2, 2014. |
Search Opinion for European Patent Application No. 12877833.9. |
Number | Date | Country | |
---|---|---|---|
20210106400 A1 | Apr 2021 | US |
Number | Date | Country | |
---|---|---|---|
61653967 | May 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14404518 | US | |
Child | 17130691 | US |